CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395 | +44 (0) 20 3951 8071
info@oxonepi.com

Tag: News

""

OXON EPIDEMIOLOGY AT WORLD DRUG SAFETY CONGRESS 2019

OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.

""

OXON EPIDEMIOLOGY AT ISPE ANNUAL MEETING

OXON will be supporting the International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) in Philadelphia on August 24-28, 2019.

JOIN US AT DIA EUROPE 2019 – BOOTH B36

Visit our booth B36 at DIA. If you are interested in an optimal safety (PASS) study, OXON’s expert team, supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene and Tropical Medicine can help you face your PASS and PAES challenges.

THANKS FOR VISITING OUR BOOTH AT ISPOR EUROPE 2018

OXON will be exhibiting and presenting at ISPOR in Barcelona. OXON’s focus during the event will be HEOR within observational studies.

OXON AT ISPOR EUROPE 2018

OXON will be exhibiting and presenting at ISPOR in Barcelona. OXON’s focus during the event will be HEOR within observational studies.

OXON won prize at ICPE 2018 for PRAC-Approved Novel PASS Design

We were delighted to win first prize in the BRACE poster award for a novel hybrid design for a 6-country study approved by PRAC at ISPE International Conference in Prague.

OXON at the The Global Clinical Trials Connect 2018 conference

Nawab Qizilbash will speak and show a selection of practical examples and case studies under the title “Trials with observational designs”

OXON will present at the EFPIA PV Expert Group

OXON will present a review and discuss lessons learned from risk minimisation evaluation studies at the EFPIA PV Expert Group

Thanks for visiting us at ISPE annual meeting – ICPE 2017

We would like to thank you for visiting our booth at ISPE 2017 ANNUAL MEETING that was held in the Palais de Congress de Montreal from August 26 to August 30.

OXON at ISPOR European Congress 2017

OXON will be presenting at the 20th Annual European Congress of ISPOR:
two poster presentations focused on Clinical Outcomes Studies